RSS Takeda Reports Approval Of HYQVIA Injection Set In Japan - Quick Facts

Currently reading:
 RSS Takeda Reports Approval Of HYQVIA Injection Set In Japan - Quick Facts

Status
Not open for further replies.

Crax Bot

Staff member
Administrator
Amateur
LV
0
Joined
Nov 5, 2021
Threads
9,822
Likes
1,923
Credits
33,507©
Cash
0$
Takeda (TAK) has announced that the Japanese Ministry of Health, Labour and Welfare has granted approval for the use of the HYQVIA 10% Subcutaneous injection set in patients with agammaglobulinemia or hypogammaglobulinemia. HYQVIA stands as the inaugural plasma-derived therapy for subcutaneous administration in Japan, comprising a combination of an Immunoglobulin 10% vial and a Recombinant Human Hyaluronidase PH20 vial.

"We are thrilled that HYQVIA, already approved in over 40 countries globally, has now received approval in Japan," stated Naoyoshi Hirota, Regional Head of Research & Development for Takeda's Plasma-Derived Therapies Business Unit in Japan.

The material has been provided by InstaForex Company - www.instaforex.com
 
Status
Not open for further replies.
Tips

Similar threads

Top Bottom